prednisone has been researched along with Muscular Dystrophy, Facioscapulohumeral in 1 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
Muscular Dystrophy, Facioscapulohumeral: An autosomal dominant degenerative muscle disease characterized by slowly progressive weakness of the muscles of the face, upper-arm, and shoulder girdle. The onset of symptoms usually occurs in the first or second decade of life. Affected individuals usually present with impairment of upper extremity elevation. This tends to be followed by facial weakness, primarily involving the orbicularis oris and orbicularis oculi muscles. (Neuromuscul Disord 1997;7(1):55-62; Adams et al., Principles of Neurology, 6th ed, p1420)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Tacrolimus was treated to a goal serum trough of > 5 ng/mL and prednisone was tapered every month." | 1.62 | Adapting MRI as a clinical outcome measure for a facioscapulohumeral muscular dystrophy trial of prednisone and tacrolimus: case report. ( Bindschadler, M; Friedman, SD; Johnstone, LM; Tapscott, SJ; Wang, LH, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, LH | 1 |
| Johnstone, LM | 1 |
| Bindschadler, M | 1 |
| Tapscott, SJ | 1 |
| Friedman, SD | 1 |
1 other study available for prednisone and Muscular Dystrophy, Facioscapulohumeral
| Article | Year |
|---|---|
Adapting MRI as a clinical outcome measure for a facioscapulohumeral muscular dystrophy trial of prednisone and tacrolimus: case report.
Topics: Humans; Magnetic Resonance Imaging; Male; Middle Aged; Muscle, Skeletal; Muscular Dystrophy, Faciosc | 2021 |